These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. There are no neurophysiologic features characteristic of "axonal" Guillain-Barré syndrome. Cros D, Triggs WJ. Muscle Nerve; 1994 Jun; 17(6):675-7. PubMed ID: 8196711 [Abstract] [Full Text] [Related]
3. Axonal form of Guillain-Barré syndrome: evidence for macrophage-associated demyelination. Berciano J, Coria F, Montón F, Calleja J, Figols J, LaFarga M. Muscle Nerve; 1993 Jul; 16(7):744-51. PubMed ID: 8505931 [Abstract] [Full Text] [Related]
4. Axonal damage in Guillain-Barré syndrome. van der Meché FG, Meulstee J, Kleyweg RP. Muscle Nerve; 1991 Oct; 14(10):997-1002. PubMed ID: 1944413 [Abstract] [Full Text] [Related]
5. Pathology of the motor-sensory axonal Guillain-Barré syndrome. Griffin JW, Li CY, Ho TW, Tian M, Gao CY, Xue P, Mishu B, Cornblath DR, Macko C, McKhann GM, Asbury AK. Ann Neurol; 1996 Jan; 39(1):17-28. PubMed ID: 8572662 [Abstract] [Full Text] [Related]
6. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Hadden RD, Cornblath DR, Hughes RA, Zielasek J, Hartung HP, Toyka KV, Swan AV. Ann Neurol; 1998 Nov; 44(5):780-8. PubMed ID: 9818934 [Abstract] [Full Text] [Related]
7. [Electrodiagnostic features in inflammatory demyelinating polyneuropathy]. Baba M, Ozaki I. Rinsho Shinkeigaku; 1995 Dec; 35(12):1365-7. PubMed ID: 8752397 [Abstract] [Full Text] [Related]
8. Multifocal motor neuropathy with conduction block: Distribution of demyelination and axonal degeneration. Vucic S, Black K, Chong PS, Cros D. Clin Neurophysiol; 2007 Jan; 118(1):124-30. PubMed ID: 17095292 [Abstract] [Full Text] [Related]
9. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome. Kuwabara S, Yuki N, Koga M, Hattori T, Matsuura D, Miyake M, Noda M. Ann Neurol; 1998 Aug; 44(2):202-8. PubMed ID: 9708542 [Abstract] [Full Text] [Related]
10. [Guillain-Barré syndrome. Variation on the theme]. Karlsen B, Vedeler C. Tidsskr Nor Laegeforen; 1996 Jan 20; 116(2):242-5. PubMed ID: 8633333 [Abstract] [Full Text] [Related]
11. Correlations of nerve conduction measures in axonal and demyelinating polyneuropathies. Tankisi H, Pugdahl K, Johnsen B, Fuglsang-Frederiksen A. Clin Neurophysiol; 2007 Nov 20; 118(11):2383-92. PubMed ID: 17900975 [Abstract] [Full Text] [Related]
12. [Sequential studies of motor nerve conduction in relation to the disease stages of Guillain-Barré syndrome]. Kinoshita A, Kawamura J, Hashimoto S, Yamamoto T, Kubori T. Rinsho Shinkeigaku; 1993 Jun 20; 33(6):600-5. PubMed ID: 8403678 [Abstract] [Full Text] [Related]
13. Criteria for demyelination based on the maximum slowing due to axonal degeneration, determined after warming in water at 37 degrees C: diagnostic yield in chronic inflammatory demyelinating polyneuropathy. Van Asseldonk JT, Van den Berg LH, Kalmijn S, Wokke JH, Franssen H. Brain; 2005 Apr 20; 128(Pt 4):880-91. PubMed ID: 15689367 [Abstract] [Full Text] [Related]
14. Circulating tumor necrosis factor-alpha correlates with electrodiagnostic abnormalities in Guillain-Barré syndrome. Sharief MK, Ingram DA, Swash M. Ann Neurol; 1997 Jul 20; 42(1):68-73. PubMed ID: 9225687 [Abstract] [Full Text] [Related]